Story perspectives

Quintessence Psychiatry Enhances ADHD Diagnosis with New Tool

10/14/2025

Summary

Story summary

Quintessence Psychiatry has adopted Mentavi Health’s asynchronous Diagnostic Evaluation for adult attention-deficit/hyperactivity disorder (ADHD).
Patients complete the assessment at home in 60–90 minutes, with results in about five days.
Barry K. Herman, Mentavi’s chief medical officer, says timely assessments can improve outcomes and reduce the cost of untreated ADHD, estimated at over $120 billion annually.
The evaluation addresses adult ADHD diagnostic challenges and improves access for underserved populations.

1 of 1

Story summary

Quintessence Psychiatry has adopted Mentavi Health’s asynchronous Diagnostic Evaluation for adult attention-deficit/hyperactivity disorder (ADHD).
Patients complete the assessment at home in 60–90 minutes, with results in about five days.
Barry K. Herman, Mentavi’s chief medical officer, says timely assessments can improve outcomes and reduce the cost of untreated ADHD, estimated at over $120 billion annually.
The evaluation addresses adult ADHD diagnostic challenges and improves access for underserved populations.